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Maternal Tiredness and Cytokine Concentrations in Mid-Pregnancy  
Abstract 
Objective 
Sleep disturbances relate to altered levels of inflammatory mediators in general population, but not much is 
known about the associations between sleep disturbances and inflammatory mediators during pregnancy. 
The present exploratory study investigated whether insomnia, tiredness, general sleep quality, and 
insufficient sleep duration during pregnancy relate to the concentrations of maternal peripheral circulating 
cytokines. As sleep disturbances are frequently observed in mood disorders, the results were controlled for 
symptoms of depression and anxiety. 
Methods 
137 participants were randomly drawn from a representative FinnBrain Birth Cohort. Serum concentrations 
of selected cytokines were analyzed using Multiplex bead arrays from blood samples drawn at the 
gestational week 24. The sleep disturbances were evaluated using the Basic Nordic Sleep Questionnaire. 
Depressive and anxiety symptoms were measured with the Edinburgh Postnatal Depression Scale and the 
anxiety subscale of the self-rated Symptom Checklist 90, respectively. 
Results 
Enhanced tiredness was associated with cytokine concentrations of IL-2, IL-10, IL-12, IL-13, and TNF-α. 
The observed associations resembled a reversed U-shaped curve rather than being linear. Having a good 
general sleep quality was associated with higher logarithmic cytokine concentrations  of IL-2, IL-4, IL-6, IL-
10, IL-12, IL-13, and IFN-γ. There was no evidence for associations between insomnia or sleep loss and 
cytokines. 
Conclusions  
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Maternal subjective tiredness and good general sleep quality were associated with altered levels of 
immunological markers during pregnancy. The association was independent from symptoms of depression 
and anxiety.  
Keywords: Cytokines, Immunology, Pregnancy, Sleep, Sleep Quality, Tiredness 
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1. Introduction  
Sleep disturbances with varying severity are reported by approximately 84% of women during pregnancy (1). 
Pregnancy-related sleep disturbances include sleep onset insomnia, sleep maintenance insomnia, as well as 
shortening of sleep duration along pregnancy (2,3). Sleep disordered breathing, especially snoring, is also 
common (2,3,4). Sleep disturbances in pregnancy may result in sleepiness, a subjective feeling of tiredness 
associated with increased sleep propensity, during wake hours (5,6). Increased rates of fatigue and 
sleepiness are frequently observed throughout normally progressing pregnancies (4,6,7). Reportedly, women 
also take more naps during pregnancy compared to non-pregnant women (3,4). 
Cytokines are signaling proteins of the immune system that are stimulated by infections and other types of 
inflammation, psychological stress, as well as sleep disturbances (8,9,10,11,12,13,14). Cytokines may be 
further divided into proinflammatory T-helper 1 lymphocyte produced cytokines (Th1 cytokines, such as 
IFN-γ, IL-6, and IL-12) and anti- inflammatory T helper 2 lymphocyte produced cytokines (Th2 cytokines, 
such as IL-4 and IL-13), depending on the response they provoke in the body (13,15). Th1 cytokines are 
typically induced in anti-microbial and autoimmune immune responses, whereas Th2 cytokines counteract 
the effects of Th1 cytokines and Th2 cytokines also play a dominant role in allergic reactions. However, 
while the traditional Th1:Th2 dichotomy to classify different cytokines is often used, it is an oversimplified 
description of cytokine functions (15).  
Pregnancy induces changes in maternal cytokine levels, in order to prevent fetus rejection (16). There is a 
trend for overexpression of Th2 produced anti- inflammatory cytokines in early pregnancy and a shift 
towards a Th1 produced proinflammatory cytokine profile when the pregnancy proceeds towards parturition 
(17). For parturition, proinflammatory cytokines play a central role as they increase the production of 
prostaglandins and matrix-degrading enzymes that are required in the process of inducing labor (17). Higher 
peripheral concentrations of certain proinflammatory cytokines, e.g. IL-2, IL-6, IL-12, and IFN-γ, have been 
shown to associate with preterm delivery (10,18,19). 
In general, sleep disturbances have been related to altered levels of inflammatory mediators, especially to 
IL-6, CRP and TNF-α (8,12,14,20,21), although also contradictory findings have been published (22). 
Knowledge about possible associations between sleep disturbances and cytokine levels in pregnancy is 
scarce. Diminished overall sleep quality in early and late pregnancy has been related to increased TNF-α and 
IL-6 concentrations, respectively (10,11). Disturbances in overall sleep quality have also been associated 
with increased IL-8 in mid-pregnancy, but only among women with African American ethnicity (23). When 
analyzed in more detail, a prolonged sleep latency has been related to decreased IL-4 and IL-6 
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concentrations in the 2nd trimester, and a shortened sleep duration during the 2nd and 3rd trimester with 
enhanced IL-6 production in the 3rd trimester (10,11,23). Among pregnant women with depression, low 
sleep efficiency (the ratio of the total sleep duration at night compared to the time spent in bed) has been 
shown to relate to higher IL-6, whereas a greater amount of naps and shorter sleep duration (<7h per night) 
have been associated with higher TNF-a levels, and with higher IL-8 levels, respectively (24). As depression 
may alter cytokine levels, these results are not easily comparable with those of non-depressed pregnant 
women (24,25,26,27,28). However, the association between decreased sleep efficiency and enhanced IL-6 
production has also been observed among non-depressed women in late pregnancy (10). Sample sizes in the 
above-mentioned studies have been rather small, and possible confounding factors, such as body mass index 
(BMI) and age, have not been routinely controlled for. 
Our aim was to conduct an exploratory study to investigate whether insomnia, tiredness, general sleep 
quality, and insufficient sleep duration during pregnancy are associated with the concentrations of maternal 
peripheral circulating cytokines. Compared to the previous studies investigating associations between sleep 
disturbances and cytokines among pregnant women (10,11,23,24), a wider range of pro- and anti-
inflammatory cytokines was under interest in the present study. We hypothesized that sleep disturbances, 
presenting as greater levels of insomnia, tiredness, and sleep loss, and as lessened general sleep quality, 
would be associated with a proinflammatory immune response. We have previously observed that maternal 
prenatal symptoms of depression and anxiety are positively associated with peripheral circulating cytokines 
IL-5, IL-9, and IL-13 in mid-pregnancy (26). Also, as sleep disturbances are frequently observed in 
depression and anxiety, symptoms of depression and anxiety were controlled for in the present study (29).  
2. Methods 
2.1. Participants 
The study population has been previously described (26) and, hence, only a brief description is given here. 
The study participants were drawn from a larger population-based pregnancy cohort, the FinnBrain Birth 
Cohort Study (www.finnbrain.fi) (30), currently ongoing in Southwest Finland. The first consecutive 150 
pregnant women participating in the cohort and attending the mid-pregnancy laboratory visit were included 
as potential subjects in the present study. Exclusion criteria included acute infection (n=4), any chronic 
inflammatory condition or autoimmune disorder (n=6) and use of oral corticosteroids (n=1). These exclusion 
criteria data were gained from the participants’ self-reports and monitored by the research nurse at the 
laboratory visit. Further, two subjects were excluded due to missing data in the relevant sleep questionnaires. 
Thus, after the exclusions, 137 subjects aged from 19 to years 42 were included in the study sample. 
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The study protocol was approved by the Ethics Committee of Hospital District of Southwest Finland 
(ETMK 57/180/2011). The subjects gave their written informed consent after they received oral and written 
information on the study.  
2.2. Questionnaires 
Data on background and potential confounding variables were collected via self- report questionnaires 
delivered to the participants at gestational week (gwk) 14 or from the Finnish National Birth Register kept 
by the National Institute for Health and Welfare (www.thl.fi). These data included information on maternal 
alcohol consumption (frequency and amount), smoking (current smoking yes/no, the number of 
cigarettes/day), asthma (yes/no), allergies (yes/no), gestational diabetes (yes/no), and maternal age at 
delivery. Maternal pre-pregnancy BMI (kg/m2) was collected from maternity clinic records (missing BMI 
values were imputed by the study population median value for four subjects). The level of education was 
defined as low (basic education, 9 years), medium (undergraduate studies, vocational education, 9-12 years), 
or high (university degree or comparable, over 12 years) (26).  
The questionnaires concerning sleep quality and quantity, depressive symptoms and overall anxiety were 
sent to the participants at gwks 14, 24 and 34, representing the second, and the third trimesters. Responses 
concurrent with the collection of venous blood samples (gwk 24) were used for the analyses of the present 
study. Missing data concerning gwk 24 sleep items were imputed for 13 subjects by using their responses on 
gwk 14 questionnaires. The number of missing sleep items was one or two for ten subjects, and five for one 
subject. Two subjects did not have any sleep data from gwk 24, and all their sleep data were thus derived 
from gwk 14 questionnaires. The exclusion of the three subjects whose number of imputed sleep items was 
five or more did not change the results. Thus, subjects with imputed sleep item data were not excluded from 
the sample. 
The characteristics of sleep and sleep disturbances were evaluated using the Basic Nordic Sleep 
Questionnaire (BNSQ), which includes 27 sleep related questions (31). In the present study, BNSQ 
questions concerning insomnia symptoms ([1] difficulty falling asleep, [2] monthly frequency of nocturnal 
awakenings, [3] daily frequency of nocturnal awakenings, [4] too early morning awakenings, [5] general 
sleep quality), and tiredness symptoms ([1] morning tiredness, [2] daytime tiredness, [3] napping during the 
day) were of interest. Insomnia and tiredness items were rated on a five-point-scale ranging from (1) never 
or less than once a month, 2) less than once a week, 3) 1 – 2 days a week, 4) 3 – 5 days a week, to 5) daily or 
almost daily during the past month. The insomnia score was computed by calculating the sum score of the 
following BNSQ items: difficulty falling asleep, monthly frequency of nocturnal awakenings, daily 
frequency of nocturnal awakenings, too early morning awakenings, and general sleep quality (Cronbach's 
alpha 0.71).  The tiredness score was computed by calculating the sum score of the BNSQ items of morning 
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tiredness, daytime tiredness, and napping during the day (Cronbach's alpha 0.69). Besides using the 
insomnia score, general sleep quality was used as an independent insomnia variable in subsequent analyses. 
General sleep quality was treated as a categorical variable with two categories representing good, and 
diminished general sleep quality (scale ranges 1-3, and 4-5, respectively). Sleep duration was measured as 
actual sleep duration, preferred sleep duration, and sleep loss. Average actual sleep duration and preferred 
sleep duration were inquired by the following BNSQ questions: ”How many hours do you usually sleep per 
night?” and ”How many hours of sleep do you need per night (how many hours would you sleep if you had 
the possibility to sleep as long as you need to)?”, respectively, and expressed in hours. For actual sleep 
duration and preferred sleep duration, the responses given with a range of sleeping hours (e.g. 7 – 8 h) were 
transformed into their arithmetic means (e.g. 7.5 h). Sleep loss was determined by subtracting the actual 
sleep duration from preferred sleep duration (hours). For analyses, sleep loss was divided into two 
subcategories representing sleep loss less than two hours, and sleep loss of at least two hours. 
Depressive symptoms were monitored at gwk 24 with the Edinburgh Postnatal Depression Scale (EPDS) 
(32), that is a self-report questionnaire consisting of 10 items and scored on a 4-point Likert scale (0–3 
points/item), total score thus ranging between 0 and 30. The EPDS can also be used to study prenatal 
depression (33,34).  
Symptoms of overall anxiety were assessed at gwk 24 with the anxiety subscale of the self- rated Symptom 
Checklist 90 (SCL-90-anx) (35,36). The anxiety subscale consists of 10 items scored on a 5-point Likert 
scale (0–4 points/item), and the range of the total sum score is thus 0–40.  
2.4. Cytokine concentrations  
The venous blood samples for measuring cytokine levels were drawn on gwk 24 during office hours, i.e. 
between 8 am and 4 pm. Blood samples were drawn by venipuncture and serum was separated, aliquoted 
and stored at -70 °C until analyses. The cytokine concentrations were analyzed in a single assay run using 
Bio-Plex Pro Human Cytokine 21- and 27-Plex Assay kits (Bio-Rad, Hercules, CA). The amount of beads, 
detection antibodies and streptavidin-phycoerythrin conjugate were used at half of their recommended 
concentrations, as previously described (26,37,38,39,40,41). 
In our previous study, associations between maternal prenatal depressive and anxiety symptoms and 
concentrations of the cytokines IL-4, IL-5, IL-6, IL-9, IL-10, IL-12, IL-13, TNF-α, and interferon gamma 
(IFN-γ), were investigated (26). As depression and anxiety are associated with sleep disturbances, the aim in 
the present study was to investigate if maternal sleep characteristics had independent associations with these 
cytokine concentrations during pregnancy (29). Along with the aforementioned cytokines, the 
proinflammatory cytokines IL-1β, IL-2 and IL-8 were additionally investigated, as they have been 
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previously reported to have associations with pregnancy complications and sleep problems or disorders 
(8,15,24). IFN-γ/IL-4 ratio was calculated to illustrate a rough estimate of the Th1/Th2 balance (42). 
2.5 Statistical analyses 
2.5.1. Depressive and anxiety symptoms  
As the study participants were recruited from the general population, where the frequency of possible 
clinical depression was expectedly low, a continuous total sum score of the Edinburgh Postnatal Depression 
Scale (EPDS) (32) was used as a measure of depressive symptoms in the main analyses. For the same reason, 
a continuous sum score of the SCL-90 anxiety subscale (SCL-90-anx) (35,36) was used to measure the level 
of anxiety among the participants.  
2.5.2. Cytokines 
Logarithmic transformations of measured cytokine levels were used in the analyses to reduce skewness of 
distributions. 
2.5.3. Associations between cytokines and the sleep variables 
Standard linear regression analysis was used to study associations between the cytokines and the sleep 
variables. First, regression analysis was conducted separately for every cytokine under interest by using (the 
natural logarithm of) the cytokine concentration as the dependent variable, and the tiredness score, the 
insomnia score , the dichotomous sleep loss and the selected covariates (BMI, age, depressive and anxiety 
symptoms) as independent variables. Associations between the tiredness score and each cytokine were 
modeled by natural cubic splines (43) with two degrees of freedom to be able to model the non-linear 
associations between them (see Figure 1). To investigate possible associations between cytokines and 
general sleep quality, similar regression analysis was conducted for every cytokine under interest by using 
the dichotomous general sleep quality and the selected covariates as independent variables. Covariate 
selection was conducted according to the observed associations between potential covariates (depressive 
symptoms, symptoms of anxiety, age, and BMI) and cytokines in our previous study (26). Additionally, in a 
large-scale population study IL-2, IL-5, IL-10, IL-12, IL-13, and TNF-α have been associated with BMI 
among non-pregnant women (40). Additionally, age is linked with some peripheral cytokine profiles (26,44). 
As the present study is among the first to investigate a larger set of cytokines in the context of maternal 
prenatal sleep characteristics, these analyses were considered explorative and the significance level was set 
at the p value of 0.05. All the analyses were made using R (45) with the packages ggplot2 (46) for Figure 1 
and splines (45) for fitting natural cubic spline curves. 
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3. Results 
Description of the study population 
The study population characteristics and descriptive statistics of the sleep and cytokine variables are 
presented in Tables 1, 2, and 3, respectively.  
- insert Table 1 about here – 
- insert Table 2 about here– 
- insert Table 3 about here– 
Insomnia  
In the regression analyses, the insomnia score was not associated with any logarithmic cytokine 
concentration (Table 4).  
Sleep quality  
In all, 121 (88.3%) women reported having good, and 16 (11.7%) women diminished general sleep quality. 
Having a good general sleep quality was associated with higher logarithmic cytokine concentrations of IL-2, 
IL-4, IL-6, IL-10, IL-12, IL-13, and IFN-γ (Table 5).  
Tiredness 
The tiredness score was associated with cytokine concentrations of IL-2, IL-10, IL-12, IL-13, and TNF-α 
(Table 4). As seen in Figure 1, the observed associations between the tiredness score and logarithmic 
cytokine concentrations resembled a reversed U-shaped curve rather than linear (Figure 1).  
Sleep loss 
105 (76.6%) women had sleep loss less than two hours, and 32 (23.4%) women more than two hours. The 
amount of sleep loss did not relate to cytokine concentrations (Table 4). 
Covariates 
In the models where the three sleep score variables (insomnia  score, tiredness score, sleep loss) were entered 
simultaneously, no associations between IL-2, IL-10, IL-12, IL-13, or TNF-α logarithmic cytokine 
concentrations and the selected covariates, i.e. depressive symptoms (p=0.074 – 0.95), anxiety symptoms 
(p=0.45 – 0.82), age (p=0.078 – 0.50), or BMI (p=0.071 – 0.67), were observed. 
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When analyzing the associations between general sleep quality and the cytokine concentrations, age was 
related to IL-10 (p=0.019), and IL-12 (p=0.031), and BMI to IL-12 (p=0.050), and IL-13 (p=0.030).  
- insert Table 4 about here – 
- insert Figure 1 about here – 
- insert Table 5 about here – 
4. Discussion 
Our hypothesis of an association between maternal prenatal sleep disturbances and peripheral pro-
inflammatory cytokine concentrations was supported partially. Both tiredness and the general sleep quality 
had associations with IL-2, IL-10, IL-12, and IL-13. Additionally, tiredness was related to TNF-α and the 
general sleep quality was associated with IL-4, IL-6, and IFN-γ concentrations. To our best knowledge, this 
is the first time when associations between maternal prenatal tiredness and these cytokines have been 
reported. 
There are earlier findings on the association between poor sleep quality and enhanced inflammatory 
processes in all phases of pregnancy (10,11,23). Conflicting these findings, good general sleep quality was 
related to heightened IL-2, IL-4, IL-6, IL-10, IL-12, IL-13, and IFN-γ cytokine levels in mid-pregnancy in 
the present study. Discrepancy between the results could be at least partly explained by differences in 
methodology. In the previous studies, overall sleep quality has been measured by a total score in the 
Pittsburgh Sleep Quality Index (PSQI), which includes variety of sleep disturbance items, while in the 
present study general quality of sleep was measured as a subjective estimation of sleep quality (10,11,23). 
There is an earlier study showing that compromised subjective quality of sleep relates to enhanced IL-6 
production while stimulated with Escherichia coli endotoxin (10). According to the results of the present 
study, positive associations between good subjective sleep quality and cytokines might also be present 
without any stimulation and concern wider range of cytokines that earlier observed.  
Previous studies have also yielded scattered evidence that also prolonged sleep latency, poor sleep 
continuity, and shortened sleep duration relate to altered levels of immunological responses during 
pregnancy (10,11,23,24). However, insomnia or sleep loss were not associated with the level of peripheral 
cytokines in the present study, where depressive symptoms, the level of anxiety, BMI, and age were 
controlled for. This implies that similarly as among non-pregnant women, also during pregnancy disturbed 
sleep in general may not relate to altered immunological responses (47). Different types of sleep 
disturbances may represent distinctive phenotypes that correspond with differential immunological 
mechanisms, and for example, may rather relate to a disturbed Th1/Th2 balance, than to isolated altered 
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cytokine concentrations (48). A mediating agent in these associations might be melatonin that, –besides to 
the sleep-wake rhythm-, is shown also to regulate immunological processes on a larger scale (49).  
Approximately one-fourth of pregnant women report sleepiness in mid- and late pregnancy (6). While the 
frequency of sleep disturbances increases as the pregnancy proceeds, the frequency of sleepiness seems to 
remain stable over mid- and late pregnancy (6). Thus, it is possible that sleepiness in pregnancy may not 
totally result from disrupted sleep (6). Inflammatory mechanisms, especially cytokine IL-6, have been 
related –in non-pregnant populations- to daytime fatigue in the absence and the presence of medical 
conditions, e.g. multiple sclerosis and cancer (50,51,52,53). According to the present study, inflammatory 
mechanisms may relate to increased tiredness or subjective tiredness also in pregnancy. As pregnant women 
experience more tiredness than non-pregnant women, our notion that the increased tiredness even in this 
population is associated with a distinct peripheral inflammatory marker pattern, is interesting and potentially 
important (5,6). 
Even though cytokines relate strongly and widely to each other and to CRP, a multivariate model showed 
that they rather function as independent risk factors than relate to tiredness and good general sleep quality as 
a solid group (40). The role of cytokines IL-1 and TNF-alfa as sleep promotors has been well documented 
(54,55). Evidence also suggests that other cytokines regulate the sleep-wake rhythm (54). For an example, 
whereas IL-1, IL-2, IL-6, and IL-8 promote sleep, IL-4, IL-10, and IL-13 seem to reduce sleep by inhibiting 
the production of sleep promoting cytokines (54). However, the roles of individual cytokines in sleep 
regulation seem to be complex, as in certain concentration one cytokine may function as a sleep promoter 
and in another as a sleep inhibitor (54,55). Interestingly, the observed associations between peripheral 
cytokines and tiredness were not linear, but rather resembled a reversed U-shaped curve. An earlier 
observation has also shown that the association between IL-1 and sleep propensity might resemble a 
reversed U-shaped curve; i.e. whereas in general IL-1 is a sleep inductor, in high doses it becomes a sleep 
inhibitor (55). It is possible that a negative feedback- loop regulates the level of circulating cytokines by 
decreasing production of previously overproduced peripheral cytokines in case of prolonged Th1 and Th2 
cell responses (56). Also, prolonged or frequent tiredness may induce or result from chronic stress that –via 
for instance cortisol dysfunction- has potential to produce inflammatory responses that are distinct from 
inflammatory responses related to short exposure to stressful events (57). Although the mechanisms behind 
the observed U-shaped association between tiredness and peripheral cytokines were out of the scope of the 
present study, to our knowledge this is a novel finding regarding a range of cytokines, and warrants further 
investigation. 
In non-pregnant populations, disrupted sleep is related to various negative health consequences, such as 
increased risk for diabetes, elevated blood pressure and obesity (58,59). Growing evidence suggests that also 
maternal prenatal sleep disturbances may indicate an increased risk for pregnancy and delivery 
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complications. Insomnia, shortened sleep duration and sleep deprivation, sleepiness, and decreased sleep 
quality are reportedly associated, for example, with preterm labor and preeclampsia, as well as longer 
delivery and operative deliveries, especially caesarean sections (23,60,61,62,63,64,65,66,67,68). Possible 
mechanisms that mediate the above-mentioned risks may include elevated levels of stress hormones, 
inflammatory parameters and cytokines, that have been observed among individuals with sleep disturbances 
(12,13,22,23,66,67,69). In our population, multivariable analyses showed that maternal subjective tiredness 
and good general sleep quality explained certain cytokine levels after controlling for the effects of 
depressive and anxiety symptoms. However, the present study does not provide any information on the 
potential causality of the relationships. 
Strengths and limitations  
Our study was merited by a randomly selected sample representing a generally healthy female population. 
As the population was relatively healthy in terms of psychiatric symptoms, extension of our findings to 
psychiatric populations needs further research. The sample size in the present study is larger than in previous 
studies among pregnant women. However, even larger samples with repeated assessments would further 
strengthen power of the study. The present study should also be considered as exploratory, and future studies 
are needed to investigate associations between cytokines and sleep disturbances in pregnancy.  
Immunological responses relating to sleep disturbances seem to vary according to the phase of pregnancy, 
and between women with different ethnicities (10,11,23,24). In addition, cortisol levels were not measured 
from the participants. This should be considered as a limitation as cortisol is an important modulator of both, 
the immune system, as well as the sleep-wake rhythm (54,57). 
Another strength of this study was the broader range of cytokines compared to previous studies. However, 
we studied only a single cytokine sample at one time point during the second trimester, which precludes any 
conclusions on causality or the sequence of the phenomena, and may hinder comparisons to other studies 
(11). The blood samples were taken during office hours and detailed data on the timing of individual 
samples was not available. This can be considered as a limitation, as some cytokines are secreted with 
diurnal fluctuations (70).  
The questionnaire we used, the BNSQ, is validated and widely used in different populations (31). It contains 
a wide panel of sleep items and therefore provides precise information on sleep disturbances and tiredness. 
Further studies using objective measures might give new perspectives into the understanding of the 
connections between sleep and inflammation. Previously, we reported that cigarette smoking was unrelated 
to cytokine concentrations in this population of pregnant women with a very low number of cigarette 
smokers and a low number of cigarettes consumed/day (26) and thus our results were not controlled for 
smoking. This precludes the extension of the results to more frequently smoking populations. 
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Conclusions 
Maternal subjective tiredness and good general sleep quality were associated with altered levels of 
immunological markers during pregnancy, the association being independent from symptoms of depression 
and anxiety. Based on earlier research, cytokine profiles might affect the course of pregnancy and delivery, 
as well as offspring health outcomes, which underlines the importance of further research in this area 
(61,63,66,67,71). While optimal sleep patterns during pregnancy are not known and probably vary between 
women, subjective tiredness and general sleep quality may present important indicators of a risk of altered 
inflammatory responses during pregnancy (61). 
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Figure Titles and Captions 
Figure 1. Associations between cytokine concentrations and the tiredness score (95% (pointwise) confidence 
bands marked with grey colour). 
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Table 1. Characteristics of the study population (n=137). 
 Mean (SD)  Range 
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or n (%) 
Age (years) 30.6 (4.8) 19-42 
BMI (kg/m
2
)
 
25.2 (4.8) 18-46 
Parity   
       Nulliparous 69 (50.4)  
       Multiparous 68 (49.6)  
Education   
       Low level 50 (36.5)  
       Middle level 36 (26.3)  
       High Level 51 (37.2)  
Marital status 
1 
  
       Married/cohabitating 131 (98.5)  
       Divorced 0 (0.0)  
       Single 2 (1.5)  
       Widowed 0 (0.0)  
Asthma 9 (6.6)  
Allergy 57 (41.6)  
Gestational diabetes 28 (20.4)  
Smoking during pregnancy   
       Non-smokers 122 (89.1)  
       Smokers 15 (10.9)  
Alcohol consumption during pregnancy   
       Non-users 112 (81.8)  
       Any use 25 (18.2)  
EPDS score 4.38 (3.56) 0-16 
SCL-90/anxiety score 2.96 (3.09) 0-15 
1
 Four missing values 
EPDS= the Edinburgh Postnatal Depression Scale 
SCL = Symptom Checklist 90 
 
Table 2. Characteristics of sleep (BNSQ= the Basic Nordic Sleep Questionnaire) (n=137). 
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 Mean (SD) Range 
Insomnia score 13.0 (3.3)  5 - 23 
     Difficulty falling asleep   1.8 (0.8)  1 -  4 
     Monthly frequency of nocturnal awakenings   4.4 (1.0)  1 -  5 
     Daily frequency of nocturnal awakenings   2.7 (0.9)  1 -  5 
     Too early morning awakenings   2.0 (1.0)  1 -  5 
     General sleep quality   2.1 (1.0)  1 -  5 
Tiredness score  7.5 (2.6)  3 - 15 
     Morning tiredness   2.6 (1.2)  1 -  5 
     Daytime tiredness   2.6 (1.1)  1 -  5 
     Napping during the day   2.3 (1.1)  1 -  5 
Sleep Duration   
     Actual length of sleep (hours)  7.8 (0.9)  6 - 11 
     Preferred duration of sleep (hours)   8.9 (1.1)  6 - 13 
     Sleep loss  1.1 (1.2) -2 -  5 
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Table 3. Cytokine concentrations (pg/mL) (n=137). 
 Mean (SD)
1 
Range Median Q1/Q3 
IL-1β 1.7 (0.2)   3.1 - 15.8 5.3 4.7 / 6.3 
IL-2 3.0 (0.3)   7.9 - 74.5 20.8 17.5 / 23.3 
IL-4 2.5 (0.1)   7.4 - 18.7 13.0 11.6 / 14.3 
IL-5 1.8 (0.3)   3.2 - 16.4 5.8 4.8 / 6.9 
IL-6 2.7 (0.3)   7.5 - 80.0 14.0 11.7 / 16.4 
IL-8 3.5 (0.3)  19.0 - 169.7 30.6 27.6 / 35.6 
IL-9 4.2 (0.7)  28.5 - 9213.3 59.2 48.3 / 79.5 
IL-10 2.1 (0.5)   2.0 - 33.6 7.5 6.0 / 10.6 
IL-12 3.3 (0.6)   9.6 - 249.5 23.7 19.9 / 34.5 
IL-13 2.7 (0.4)   6.4 - 46.9 14.2 11.3 / 17.8 
TNF-α 4.2 (0.4)  31.8 - 382.1 62.5 56.2 / 76.4 
IFN-γ 5.6 (0.2) 148.2 - 609.2 258.3 230.4 / 295.6 
IFN-γ/IL-4 20.7 (2.9) 6.1 x 10^6 - 2.6 x 10^15 8.0 x 10^8 1.9 x 10^8 / 2.6 x 10^9 
1
The means and standard deviations are calculated for logarithm transformed values, others from original values. 
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Table 4. Results of regression analyses examining the associations between  
the selected sleep variables and cytokines (n = 137). All models included all 
three sleep parameters (insomnia score, tiredness score, and sleep loss). 
 B SE B t128
* / F2, 128
**
 p  
IL-1β     
 Insomnia score 0.001 0.008 0.18
* 
0.86 
 T iredness score (2 df)
1 
  2.84
**
 0.062 
 Sleep loss (Ref = 'No') -0.084 0.057 -1.47
*
 0.14 
IL-2     
 Insomnia score -0.012 0.009 -1.41
*
 0.16 
 T iredness score (2 df)
1 
  4.86
**
 0.009 
 Sleep loss (Ref = 'No') -0.058 0.066 -0.87
*
 0.39 
IL-4     
 Insomnia score -0.006 0.004 -1.29
*
 0.20 
 T iredness score (2 df)
1 
  2.77
**
 0.067 
 Sleep loss (Ref = 'No') -0.030 0.034 -0.87
*
 0.39 
IL-5     
 Insomnia score -0.003 0.009 -0.30
*
 0.76 
 T iredness score (2 df)
1 
  1.99
**
 0.14 
 Sleep loss (Ref = 'No') -0.103 0.066 -1.56
*
 0.12 
IL-6     
 Insomnia score -0.018 0.010 -1.70
*
 0.091 
 T iredness score (2 df)
1 
  2.55
**
 0.082 
 Sleep loss (Ref = 'No') -0.121 0.079 -1.53
*
 0.13 
IL-8     
 Insomnia score -0.010 0.009 -1.06
*
 0.29 
 T iredness score (2 df)
1 
  1.96
**
 0.15 
 Sleep loss (Ref = 'No') -0.077 0.069 -1.11
*
 0.27 
IL-9     
 Insomnia score -0.020 0.023 -0.86
*
 0.39 
 T iredness score (2 df)
1 
  0.73
**
 0.48 
 Sleep loss (Ref = 'No') -0.214 0.174 -1.23
*
 0.22 
IL-10     
 Insomnia score -0.006 0.014 -0.44
*
 0.66 
 T iredness score (2 df)
1 
  4.91
**
 0.009 
 Sleep loss (Ref = 'No') -0.117 0.105 -1.11
*
 0.27 
IL-12     
 Insomnia score -0.026 0.016 -1.61
*
 0.11 
 T iredness score (2 df)
1 
  4.00
**
 0.021 
Sleep loss (Ref = 'No') -0.124 0.121 -1.02
*
 0.31 
IL-13     
 Insomnia score -0.013 0.010 -1.28
*
 0.20 
 T iredness score (2 df)
 
  4.89
**
 0.009 
 Sleep loss (Ref = 'No') -0.110 0.079 -1.41
*
 0.16 
TNF-α     
 Insomnia score -0.020 0.012 -1.71
*
 0.090 
 T iredness score (2 df)
1 
  3.35
**
 0.038 
 Sleep loss (Ref = 'No') -0.150 0.089 -1.68
*
 0.095 
IFN-γ     
 Insomnia score -0.007 0.006 -1.11
*
 0.27 
 T iredness score (2 df)
1 
  2.37
**
 0.098 
 Sleep loss (Ref = 'No') -0.079 0.048 -1.64
*
 0.10 
IFN-γ/IL-4     
 Insomnia score -0.039 0.088 -0.44
*
 0.66 
 T iredness score (2 df)
1 
  0.41
**
 0.67 
 Sleep loss (Ref = 'No') -1.063 0.664 -1.60
*
 0.11 
B = Unstandardized regression coefficient. For Sleep loss: the estimated difference  
in the (average) log-transformed cortisol levels between the groups with sleep loss (>= 2h)  
and with no sleep loss (< 2h). For Insomnia: The effect of one unit change in the insomnia score  
on the average log-transformed cortisol level.  
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SE B = Standard error (of the regression coefficient)  
t128 = t statistic (with 128 degrees of freedom)  
F2, 128 = F statistic (with 2 and 128 degrees of freedom) 
All models were adjusted for maternal symptoms of depression (EPDS), anxiety (SCL-90/anxiety),  
age, and pre-pregnancy body mass index (BMI). 
1 
The result from comparing the model with and without the two spline terms modeling  
the non-linear relationship between the Tiredness score and (average) log-transformed cytokine levels. 
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Table 5.  Results of regression analyses examining the associations  
between the general sleep quality and cytokines (n = 137).  
 General sleep quality (Ref = ´Diminished`)                     
 B SE B t128 p  
IL-1β 0.079 0.070 1.13 0.26 
IL-2 0.167 0.081 2.06 0.041 
IL-4 0.103 0.041 2.51 0.013 
IL-5 0.133 0.080 1.65 0.10 
IL-6 0.209 0.097 2.16 0.033 
IL-8 0.153 0.084 1.83 0.070 
IL-9 0.406 0.210 1.94 0.055 
IL-10 0.257 0.129 2.00 0.048 
IL-12 0.392 0.148 2.66 0.009 
IL-13 0.292 0.095 3.07 0.003 
TNF-α 0.159 0.111 1.44 0.15 
IFN-γ 0.129 0.059 2.18 0.031 
IFN-γ/IL-4 0.721 0.804 0.90 0.37 
B = Unstandardized regression coefficient. The estimated difference in the (average)  
log-transformed cortisol levels between the groups good and diminished sleep quality.  
SE B = Standard error (of the regression coefficient)  
t128 = t statistic (with 128 degrees of freedom)  
All models were adjusted for maternal symptoms of depression (EPDS), anxiety (SCL-90/anxiety),  
age, and pre-pregnancy body mass index (BMI). 
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Highlights  
 Subjective tiredness is related to altered levels of cytokines in pregnancy.  
 Good general sleep quality is associated with higher cytokine levels.  
 There was no evidence for associations between insomnia or sleep loss and cytokines. 
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